🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thibault De La Motte Rouge

Centre Eugène Marquis

ORCID: 0000-0002-0088-6003

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial”.

Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.009

N/A

0.473DataRank · unranked

7 citations

Bhavana Pothuri, Ana Oaknin, Whitney S. Graybill, Ana Beatriz Sánchez, Colleen McCormick +15 more

CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells

iScience(2021)10.1016/j.isci.2021.103348

N/A

0DataRank · unranked

20 citations

Jean‐Philippe Guégan, Christophe Ginestier, Assia Chaïbi, Alban Bessede, Emmanuelle Charafe‐Jauffret +14 more

414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer

ESMO Open(2025)10.1016/j.esmoop.2025.104985

N/A

0DataRank · unranked

0 citations

G.S. Falchook, Loïc Verlingue, L. Carter, Thibault De La Motte Rouge, C. Baldini +14 more